Skip to content
Search

Latest Stories

GPhC proposes new English language testing system for overseas pharmacy recruits

The General Pharmaceutical Council (GPhC) is proposing that overseas applicants to the registers of pharmacists and pharmacy technicians could use a recent pass of the Pharmacy Occupational English Language Test (OET) as evidence of their English language competence.

Up until now, the GPhC has only accepted a pass in the International English Language testing System (IELTS) as evidence of overseas candidates' English language skills.


This change to the guidance would give applicants an option, which assesses language skills using real healthcare communication scenarios that candidates are likely to meet in the workplace.

The Pharmacy OET would be accepted as an alternative to IELTS for eligibility to start the Overseas Pharmacists’ Assessment Programme, and for registration, the pharmacy regulator said.

The OET is the only English language test specifically for healthcare professionals. To meet the level of English language ability required, individuals taking the Pharmacy OET would be required to score at least a B in each of the four areas of reading, writing, listening and speaking in English at one sitting of the test.

This would be the equivalent of our current requirement for a recent pass of the academic version of IELTS with an overall score of at least seven and with no score less than seven in each of the four areas of reading, writing, listening and speaking at one sitting of the test.

GPhC chief executive Duncan Rudkin said: “Everyone applying to register as a pharmacist or pharmacy technician must provide evidence of the ability to communicate clearly in English, to deliver safe and effective healthcare to patients and the public in Great Britain.

“We welcome your views on our proposal to broaden the qualifications we would accept as evidence of English language skills.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less